EFTA01032816.pdf

From: David Mitchell To: Jeffrey Epstein <jeevacation(kgmail.com> Subject: Re: Date: Wed, 20 Feb 2019 17:41:01 +0000 In summary the law is: The law, known as the Medical Cannabis Patient Care Act (MCPCA), will also create a new medical cannabis tourism industry by allowing patients from states and countries with regulated markets to access Virgin Islands medical cannabis for a fee and, according to the statute, "allow non- cannabis patients worldwide to visit the Virgin Islands and receive cannabis therapy as part of an in-patient program." Three classes of cultivation will be allowed: Patients and caregivers will be permitted to grow a small quantity for personal use. "Family farms" will be allowed to cultivate up to 100 plants. Larger commercial grow operations will be allowed to grow up to 1,000 plants. The MCPCA will be tasked with regulating the medical cannabis industry by providing online "seed-to-sale" oversight, according to the law. Licenses will be provided for MMJ product manufacturing facilities to process cannabis through extraction and infusing the extracts into goods that could act as a smokeless alternative for consumers. Patients will be required to receive a medical cannabis recommendation from a health-care professional. From: David Mitchell Sent: Wednesday, February 20, 2019 12:39 PM To: Jeffrey Epstein Subject: Please confirm you received this as I am sending from a different email The idea is that in the VI Stem would build a "Community Facility" to Grow Cultivate EFTA01032816 Process Commercial production of Cannabis Under the new bill Commercial production is limited to 1000 plants per license The government of the VI could benefit by having a professional operator building and running a large central high tech facility Stem could bring it's technology , expertise and brands . The government could benefit as this could be a one stop shop for compliance and tax collection The second question , what name should I put the shares into Can we speak later about the above, David EFTA01032817